ENTRY       D10841            Mixture   Drug
NAME        Alendronic acid and colecalciferol;
            Adrovance (TN);
            Fosamax (TN)
PRODUCT     FOSAMAX PLUS D (Organon LLC)
COMPONENT   (Alendronate sodium [DR:D00939] | Alendronic acid [DR:D07119]), Cholecalciferol [DR:D00188]
CLASS       Musculo-skeletal system agent
             DG03232  Osteoporosis agent
REMARK      ATC code: M05BB03
            Product: D10841<US>
EFFICACY    Osteoporosis agent
  DISEASE   Osteoporosis [DS:H01593]
COMMENT     Osteoporosis, postmenopausal
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M05 DRUGS FOR TREATMENT OF BONE DISEASES
               M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
                M05BB Bisphosphonates, combinations
                 M05BB03 Alendronic acid and colecalciferol
                  D10841  Alendronic acid and colecalciferol &lt;US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Bisphosphonates
               Alendronate Sodium/ Cholecalciferol
                D10841  Alendronic acid and colecalciferol
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D10841  Alendronic acid and colecalciferol
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D10841  Alendronic acid and colecalciferol
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10841
DBLINKS     PubChem: 319902641
///
